Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,576 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate HDR-BT Consortium.
Ishiyama H, Kamitani N, Kawamura H, Kato S, Aoki M, Kariya S, Matsumura T, Kaidu M, Yoshida K, Hashimoto Y, Noda Y, Lim KHC, Kawase T, Takahashi T, Inaba K, Kumano M, Yoshikawa N, Yoshioka Y, Nakamura K, Hiratsuka J, Itami J, Hayakawa K. Ishiyama H, et al. Among authors: aoki m. Brachytherapy. 2017 May-Jun;16(3):503-510. doi: 10.1016/j.brachy.2017.01.006. Epub 2017 Feb 17. Brachytherapy. 2017. PMID: 28222973
[Changes of edema associated with I-125 prostate brachytherapy].
Aoki M, Miki K, Takahashi H, Takagi S, Fukuda I, Honda C, Kobayashi M, Egawa S, Kanehira C. Aoki M, et al. Nihon Igaku Hoshasen Gakkai Zasshi. 2005 Oct;65(4):411-8. Nihon Igaku Hoshasen Gakkai Zasshi. 2005. PMID: 16334395 Japanese.
Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis.
Satoh T, Ishiyama H, Matsumoto K, Tsumura H, Kitano M, Hayakawa K, Ebara S, Nasu Y, Kumon H, Kanazawa S, Miki K, Egawa S, Aoki M, Toya K, Yorozu A, Nagata H, Saito S, Baba S. Satoh T, et al. Among authors: aoki m. BJU Int. 2009 Apr;103(8):1064-8. doi: 10.1111/j.1464-410X.2008.08234.x. Epub 2008 Nov 25. BJU Int. 2009. PMID: 19040526
Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-risk prostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial.
Miki K, Kiba T, Sasaki H, Kido M, Aoki M, Takahashi H, Miyakoda K, Dokiya T, Yamanaka H, Fukushima M, Egawa S. Miki K, et al. Among authors: aoki m. BMC Cancer. 2010 Oct 21;10:572. doi: 10.1186/1471-2407-10-572. BMC Cancer. 2010. PMID: 20964826 Free PMC article. Clinical Trial.
Deaths within 12 months after (125)I implantation for brachytherapy of prostate cancer: an investigation of radiation safety issues in Japan (2003-2010).
Satoh T, Yamanaka H, Yamashita T, Aoki M, Egawa S, Saito S, Sakata S, Shibuya H, Sugiura N, Takahashi Y, Nishimura T, Hamada T, Miki T, Yorozu A, Dokiya T. Satoh T, et al. Among authors: aoki m. Brachytherapy. 2012 May-Jun;11(3):192-6. doi: 10.1016/j.brachy.2011.06.009. Epub 2011 Sep 17. Brachytherapy. 2012. PMID: 21925958
Analysis of prognostic factors in localized high-risk prostate cancer patients treated with HDR brachytherapy, hypofractionated 3D-CRT and neoadjuvant/adjuvant androgen deprivation therapy (trimodality therapy).
Aoki M, Miki K, Kido M, Sasaki H, Nakamura W, Kijima Y, Kobayashi M, Egawa S, Kanehira C. Aoki M, et al. J Radiat Res. 2014 May;55(3):527-32. doi: 10.1093/jrr/rrt134. Epub 2013 Dec 17. J Radiat Res. 2014. PMID: 24351458 Free PMC article. Clinical Trial.
3,576 results